News & Events
Verva Announces Results of Successful VVP808-002 Phase 2 Clinical Trial in Type 2 Diabetes
06 / 06 / 2012
Video ABC Local: Air expanders lets breast cancer patients recover slowly
26 / 04 / 2012
Video with the Air expanders device in use and in part presented by Scott Dodson (AirXpanders CEO).
Neuromonics Offers 8 Tips on Dealing With Tinnitus Diagnosis
28 / 03 / 2012
New tinnitus treatments, experienced audiology professionals give hope to sufferers
Euthymics Bioscience Inc. initiates clinical trial for new drug targeted for adult ADHD
22 / 03 / 2012
Euthymics Bioscience, Inc. today announced that it has initiated a Phase 1 clinical trial of EB-1020, a next-generation drug in development for treating adult attention deficit hyperactivity disorder (ADHD), with low risk of drug abuse liability. This would meet a critical need because current stimulants used to treat ADHD are tightly regulated and often in short supply due to their addictive properties. Peer-reviewed preclinical data demonstrated that EB-1020 affects areas of the brain associated with ADHD. Dosing of healthy volunteers in the EB-1020 Phase 1 trial is now underway. Final results of the study are expected late this summer.
Spinifex Pharmaceuticals, receiving Emerging Company of the Year award
22 / 03 / 2012
Dr. Joshua Funder, Director, Spinifex Pharmaceuticals, Australia receiving Emerging Company of the Year award from Dr. Nazlee Kamal and Mr. Abraham Matthew
Sunshine Heart Announces FDA Completes Review of C-Pulse® Feasibility Data
16 / 03 / 2012
Sunshine Heart, Inc. (NASDAQ: SSH, ASX: SHC) today announced that the Center for Devices and Radiological Health(CDRH) of the United States Food and Drug Administration(FDA) completed its review of Sunshine Heartâ??s Investigation Device Exemption(IDE) for the C-Pulse Heart Assist System feasibility trial.